Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEXTENZA vs Topical Steroids in Cataract Surgery
NCT04479748Phase 4Completed
- Sponsor
- PRISM Vision Group
- Start
- Oct 2020
- Primary completion
- Dec 2022
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ozurdex in ocular inflammation, sponsored by PRISM Vision Group. Started Oct 2020; status: completed.
02
Drugs
ozurdex
03
Conditions
ocular inflammation
Beyond the preview
Go deeper on NCT04479748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04479748.